SPP1 and obesity due to melanocortin 4 receptor deficiency: Would the LF–OPN complex be capable of blunting obesity, dyslipidemia, metabolic endotoxemia, and gut–liver axis pathogenesis (responsible for the development and progression of metabolic associated fatty liver disease)?